Our electronic newsletter is considered by many subscribers - whether
state legislators or drug industry lobbyists - to be the single best
source of news about state and national policy initiatives as well as
the pharmaceutical industry's activities.
The newsletter has a particular focus on state policy and state
legislators, but also includes information on everything from drug
industry profit margins to international trade issues. The email newsletters are archived and the articles themselves are searchable.
Although the newsletter is available to anyone who signs up, we do
require completion of complete contact information. Members of the
news media may also wish to sign up for news releases in the Press